Baxter buys cancer drugs from Italian drugmaker for $900 mln
May 12, 2015 at 09:24 AM EDT
May 12 (Reuters) - Baxter International Inc said it agreed to buy Italian drugmaker Sigma-Tau Finanziaria SpA's portfolio of drugs to treat rare forms of blood cancer for $900 million, before expenses.
